Literature DB >> 30520087

Phenotypes of atopic dermatitis identified by cluster analysis in early childhood.

Euri Seo1, Jisun Yoon2, Sungsu Jung3, Jina Lee3, Beom Hee Lee3, Jinho Yu3.   

Abstract

Atopic dermatitis is a chronic, relapsing, inflammatory skin disease that usually appears in early childhood and develops into a heterogeneous disease during childhood. The clinical course and treatment for atopic dermatitis can differ according to its phenotype and/or endotype. This study aimed to identify clinical phenotypes of atopic dermatitis in early childhood. Data were obtained from 572 children under 3 years of age with atopic dermatitis. Cluster analysis applied to 11 variables, and we identified four clusters of atopic dermatitis. Children in cluster A (n = 141) had early-onset atopic dermatitis with high blood eosinophil counts, serum total immunoglobulin E and rates of sensitization to food allergens. Children in cluster B (n = 218) had early-onset atopic dermatitis with low blood eosinophil counts, serum total immunoglobulin E and rates of sensitization to both food and inhalant allergens. Children in cluster C (n = 53) had early-onset atopic dermatitis with high C-reactive protein levels and white blood cell counts. Children in cluster D (n = 160) had middle-onset atopic dermatitis with high serum total immunoglobulin E and rates of sensitization to inhalant allergens. Cluster A had the highest Scoring for Atopic Dermatitis and transepidermal water loss values. Age at onset, age at diagnosis, white blood cell count, eosinophil count, C-reactive protein and serum total immunoglobulin E level were the strongest predictors of cluster assignment. Analysis of these six variables alone resulted in correct classification of 95.5% of the subjects. These results support the heterogeneity of atopic dermatitis, even in early childhood.
© 2018 Japanese Dermatological Association.

Entities:  

Keywords:  atopic dermatitis; child, preschool; cluster analysis; infant; phenotype

Mesh:

Year:  2018        PMID: 30520087     DOI: 10.1111/1346-8138.14714

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  10 in total

1.  Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children: A cohort study.

Authors:  Joy Wan; Nandita Mitra; Ole J Hoffstad; Albert C Yan; David J Margolis
Journal:  J Am Acad Dermatol       Date:  2019-05-11       Impact factor: 11.527

Review 2.  Aryl Hydrocarbon Receptors: Evidence of Therapeutic Targets in Chronic Inflammatory Skin Diseases.

Authors:  Han-Bi Kim; Ji-Young Um; Bo-Young Chung; Jin-Cheol Kim; Seok-Young Kang; Chun-Wook Park; Hye-One Kim
Journal:  Biomedicines       Date:  2022-05-07

Review 3.  Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.

Authors:  Masutaka Furue; Akiko Hashimoto-Hachiya; Gaku Tsuji
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

Review 4.  Atopic Dermatitis - Current State of Research on Biological Treatment.

Authors:  Barbara Klasa; Ewa Cichocka-Jarosz
Journal:  J Mother Child       Date:  2020-07-29

5.  Classification of atopic dermatitis phenotypes according to allergic sensitization by cluster analysis.

Authors:  Hye Yung Yum; Ji Su Lee; Jung Min Bae; Sooyoung Lee; Yun Hee Kim; Myongsoon Sung; Song-I Yang; Jeongmin Lee; Mi-Hee Lee; Dong Hun Lee
Journal:  World Allergy Organ J       Date:  2022-08-03       Impact factor: 5.516

Review 6.  Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics.

Authors:  A L Bosma; A Ascott; R Iskandar; K Farquhar; J Matthewman; M W Langendam; A Mulick; K Abuabara; H C Williams; P I Spuls; S M Langan; M A Middelkamp-Hup
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-02-25       Impact factor: 9.228

7.  Atopic dermatitis trajectories to age 8 years in the GUSTO cohort.

Authors:  Noor H A Suaini; Gaik Chin Yap; Do Phuong Tung Bui; Evelyn Xiu Ling Loo; Anne Eng Neo Goh; Oon Hoe Teoh; Kok Hian Tan; Keith M Godfrey; Bee Wah Lee; Lynette Pei-Chi Shek; Hugo Van Bever; Yap Seng Chong; Elizabeth Huiwen Tham
Journal:  Clin Exp Allergy       Date:  2021-07-31       Impact factor: 5.018

Review 8.  Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis.

Authors:  Masutaka Furue
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

9.  Dendritic cell immunoreceptor drives atopic dermatitis by modulating oxidized CaMKII-involved mast cell activation.

Authors:  Xiaoyan Luo; Jingsi Chen; Huan Yang; Xinyue Hu; Martin P Alphonse; Yingchun Shen; Yuko Kawakami; Xiaoying Zhou; Wei Tu; Toshiaki Kawakami; Mei Wan; Nathan K Archer; Hua Wang; Peisong Gao
Journal:  JCI Insight       Date:  2022-03-08

10.  Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol.

Authors:  Takeshi Nakahara; Kenji Izuhara; Daisuke Onozuka; Satoshi Nunomura; Risa Tamagawa-Mineoka; Koji Masuda; Susumu Ichiyama; Hidehisa Saeki; Yudai Kabata; Riichiro Abe; Mamitaro Ohtsuki; Koji Kamiya; Tatsuro Okano; Tomomitsu Miyagaki; Yozo Ishiuji; Akihiko Asahina; Hiroshi Kawasaki; Keiji Tanese; Hiroshi Mitsui; Tatsuyoshi Kawamura; Takuya Takeichi; Masashi Akiyama; Emi Nishida; Akimichi Morita; Kyoko Tonomura; Yukinobu Nakagawa; Koji Sugawara; Chiharu Tateishi; Yoko Kataoka; Rai Fujimoto; Sakae Kaneko; Eishin Morita; Akio Tanaka; Michihiro Hide; Natsuko Aoki; Shigetoshi Sano; Haruna Matsuda-Hirose; Yutaka Hatano; Motoi Takenaka; Hiroyuki Murota; Norito Katoh; Masutaka Furue
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.